APA

Credle J. J., George J. L., Wills J., Duka V., Shah K., Lee Y., Rodriguez O., Simkins T., Winter M., Moechars D., Steckler T., Goudreau J., Finkelstein D. I. & Sidhu A. (20151224). GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein. : Cell death and differentiation.

Chicago

Credle J J, George J L, Wills J, Duka V, Shah K, Lee Y-C, Rodriguez O, Simkins T, Winter M, Moechars D, Steckler T, Goudreau J, Finkelstein D I and Sidhu A. 20151224. GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein. : Cell death and differentiation.

Harvard

Credle J. J., George J. L., Wills J., Duka V., Shah K., Lee Y., Rodriguez O., Simkins T., Winter M., Moechars D., Steckler T., Goudreau J., Finkelstein D. I. and Sidhu A. (20151224). GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein. : Cell death and differentiation.

MLA

Credle J J, George J L, Wills J, Duka V, Shah K, Lee Y-C, Rodriguez O, Simkins T, Winter M, Moechars D, Steckler T, Goudreau J, Finkelstein D I and Sidhu A. GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein. : Cell death and differentiation. 20151224.